The European Drug Agency launched its 1st Consolidated Annual Activity Report, which captures its key achievements in 2024, when it replaced the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The report reflects the agency’s 3 core drivers: health, security and business.


